Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in SEK
The 4 analysts offering 12 month price targets for Vicore Pharma Holding AB have a median target of 37.95, with a high estimate of 38.92 and a low estimate of 19.46. The median estimate represents a 442.14% increase from the last price of 7.00.
High | 456.0% | 38.92 |
Med | 442.1% | 37.95 |
Low | 178.0% | 19.46 |
Earnings history & estimates in SEK
The next earnings announcement is expected on Feb 27, 2025.
Average growth rate | -4.01% |
Average growth rate | -14.21% |
More ▼
Revenue history & estimates in SEK
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼